company background image
RAY

RaySearch Laboratories OM:RAY B Stock Report

Last Price

kr46.25

Market Cap

kr1.6b

7D

1.9%

1Y

-22.8%

Updated

03 Oct, 2022

Data

Company Financials +
RAY B fundamental analysis
Snowflake Score
Valuation5/6
Future Growth4/6
Past Performance0/6
Financial Health3/6
Dividends0/6

RAY B Stock Overview

RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide.

RaySearch Laboratories AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for RaySearch Laboratories
Historical stock prices
Current Share Pricekr46.25
52 Week Highkr74.80
52 Week Lowkr40.00
Beta1.54
1 Month Change-3.95%
3 Month Change-21.21%
1 Year Change-22.79%
3 Year Change-72.49%
5 Year Change-73.72%
Change since IPO8,061.86%

Recent News & Updates

Shareholder Returns

RAY BSE Healthcare ServicesSE Market
7D1.9%0.2%1.9%
1Y-22.8%-34.5%-26.1%

Return vs Industry: RAY B exceeded the Swedish Healthcare Services industry which returned -34.6% over the past year.

Return vs Market: RAY B exceeded the Swedish Market which returned -27.6% over the past year.

Price Volatility

Is RAY B's price volatile compared to industry and market?
RAY B volatility
RAY B Average Weekly Movement7.9%
Healthcare Services Industry Average Movement7.4%
Market Average Movement6.9%
10% most volatile stocks in SE Market11.6%
10% least volatile stocks in SE Market4.3%

Stable Share Price: RAY B is not significantly more volatile than the rest of Swedish stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: RAY B's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a376Johan Lofhttps://www.raysearchlabs.com

RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities.

RaySearch Laboratories AB (publ) Fundamentals Summary

How do RaySearch Laboratories's earnings and revenue compare to its market cap?
RAY B fundamental statistics
Market Capkr1.59b
Earnings (TTM)-kr38.38m
Revenue (TTM)kr692.84m

2.3x

P/S Ratio

-41.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
RAY B income statement (TTM)
Revenuekr692.84m
Cost of Revenuekr44.49m
Gross Profitkr648.36m
Other Expenseskr686.73m
Earnings-kr38.38m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

Nov 17, 2022

Earnings per share (EPS)-1.12
Gross Margin93.58%
Net Profit Margin-5.54%
Debt/Equity Ratio8.3%

How did RAY B perform over the long term?

See historical performance and comparison